ArticleClinical and translational radiation oncology2026
Efficacy and safety of low-dose radiotherapy in MRI-confirmed refractory chronic plantar fasciitis after extracorporeal shock wave therapy.
Article in Clinical and translational radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Treat the patient, not the MRI: Lessons from low-dose radiotherapy for plantar fasciitis.Clinical and translational radiation oncology · 2027Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Refractory chronic plantar fasciitis remains a therapeutic challenge when symptoms persist despite conservative management and advanced physical therapies. Although low-dose radiotherapy has been used as an anti-inflammatory treatment for benign musculoskeletal disorders, integrated data combining clinical, functional, quality-of-life and imaging outcomes remain limited. Methods: A longitudinal observational study was conducted in 68 patients with MRI-confirmed refractory chronic plantar fasciitis who remained symptomatic despite conservative treatment and extracorporeal shock wave therapy. All patients received low-dose radiotherapy (3 Gy in 6 fractions of 0.5 Gy). Pain (VAS), function (FFI), and health-related quality of life (EQ-5D) were assessed at baseline and at 1, 3, 6, 12 and 24 months. MRI was performed at baseline and at 3 and/or 6 months after treatment. Global clinical response integrated pain, function and quality-of-life outcomes. Results: Low-dose radiotherapy was associated with rapid and sustained improvement in pain, function and health-related quality of life. At 6 months, 95.6% of patients met criteria for global clinical response, which remained stable up to 24 months. Exploratory analyses showed that 85.1% of patients achieved a good clinical response during long-term follow-up, while 35.8% achieved an excellent response. Concordance between clinical and MRI response was limited. No radiation-related acute or late adverse events were identified. Conclusion: Low-dose radiotherapy was associated with sustained clinical benefit in MRI-confirmed refractory chronic plantar fasciitis after failure of conservative treatment and extracorporeal shock wave therapy. Clinical improvement frequently exceeded structural MRI changes, suggesting that symptomatic recovery may occur despite persistent imaging abnormalities.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.